123 related articles for article (PubMed ID: 35174530)
21. Integrin α2β1 inhibition attenuates prostate cancer cell proliferation by cell cycle arrest, promoting apoptosis and reducing epithelial-mesenchymal transition.
Salemi Z; Azizi R; Fallahian F; Aghaei M
J Cell Physiol; 2021 Jul; 236(7):4954-4965. PubMed ID: 33305380
[TBL] [Abstract][Full Text] [Related]
22. Melatonin resynchronizes dysregulated circadian rhythm circuitry in human prostate cancer cells.
Jung-Hynes B; Huang W; Reiter RJ; Ahmad N
J Pineal Res; 2010 Aug; 49(1):60-8. PubMed ID: 20524973
[TBL] [Abstract][Full Text] [Related]
23. Induction of integrin α2 in a highly bone metastatic human prostate cancer cell line: roles of RANKL and AR under three-dimensional suspension culture.
Ziaee S; Chung LW
Mol Cancer; 2014 Sep; 13():208. PubMed ID: 25200184
[TBL] [Abstract][Full Text] [Related]
24. Carbohydrate-to-carbohydrate interactions between α2,3-linked sialic acids on α2 integrin subunits and asialo-GM1 underlie the bone metastatic behaviour of LNCAP-derivative C4-2B prostate cancer cells.
Van Slambrouck S; Groux-Degroote S; Krzewinski-Recchi MA; Cazet A; Delannoy P; Steelant WF
Biosci Rep; 2014 Sep; 34(5):. PubMed ID: 25137483
[TBL] [Abstract][Full Text] [Related]
25. Cellular interactions in the tropism of prostate cancer to bone.
Sikes RA; Nicholson BE; Koeneman KS; Edlund NM; Bissonette EA; Bradley MJ; Thalmann GN; Cecchini MG; Pienta KJ; Chung LW
Int J Cancer; 2004 Jul; 110(4):497-503. PubMed ID: 15122581
[TBL] [Abstract][Full Text] [Related]
26. Molecular mechanisms of melatonin anticancer effects.
Hill SM; Frasch T; Xiang S; Yuan L; Duplessis T; Mao L
Integr Cancer Ther; 2009 Dec; 8(4):337-46. PubMed ID: 20050373
[TBL] [Abstract][Full Text] [Related]
27. Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer.
Li Y; Kucuk O; Hussain M; Abrams J; Cher ML; Sarkar FH
Cancer Res; 2006 May; 66(9):4816-25. PubMed ID: 16651437
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
29. Functional interplay between melatonin receptor-mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancer.
Tam CW; Shiu SY
J Pineal Res; 2011 Oct; 51(3):297-312. PubMed ID: 21605164
[TBL] [Abstract][Full Text] [Related]
30. The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.
Lamb LE; Zarif JC; Miranti CK
Cancer Res; 2011 Apr; 71(7):2739-49. PubMed ID: 21310825
[TBL] [Abstract][Full Text] [Related]
31. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts.
Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM
Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635
[TBL] [Abstract][Full Text] [Related]
32. A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.
Raheem O; Kulidjian AA; Wu C; Jeong YB; Yamaguchi T; Smith KM; Goff D; Leu H; Morris SR; Cacalano NA; Masuda K; Jamieson CH; Kane CJ; Jamieson CA
J Transl Med; 2011 Oct; 9():185. PubMed ID: 22035283
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer cells induce osteoblastic differentiation via semaphorin 3A.
Liu F; Shen W; Qiu H; Hu X; Zhang C; Chu T
Prostate; 2015 Mar; 75(4):370-80. PubMed ID: 25421946
[TBL] [Abstract][Full Text] [Related]
34. Aspirin inhibits highly invasive prostate cancer cells.
Lloyd FP; Slivova V; Valachovicova T; Sliva D
Int J Oncol; 2003 Nov; 23(5):1277-83. PubMed ID: 14532966
[TBL] [Abstract][Full Text] [Related]
35. Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
Hashimoto K; Ochi H; Sunamura S; Kosaka N; Mabuchi Y; Fukuda T; Yao K; Kanda H; Ae K; Okawa A; Akazawa C; Ochiya T; Futakuchi M; Takeda S; Sato S
Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2204-2209. PubMed ID: 29440427
[TBL] [Abstract][Full Text] [Related]
36. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo molecular evidence for better therapeutic efficacy of ABT-627 and taxotere combination in prostate cancer.
Banerjee S; Hussain M; Wang Z; Saliganan A; Che M; Bonfil D; Cher M; Sarkar FH
Cancer Res; 2007 Apr; 67(8):3818-26. PubMed ID: 17440096
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of matrix metalloproteinase-9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in HepG2 liver cancer cells.
Ordoñez R; Carbajo-Pescador S; Prieto-Dominguez N; García-Palomo A; González-Gallego J; Mauriz JL
J Pineal Res; 2014 Jan; 56(1):20-30. PubMed ID: 24117795
[TBL] [Abstract][Full Text] [Related]
39. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.
Xi SC; Tam PC; Brown GM; Pang SF; Shiu SY
J Pineal Res; 2000 Oct; 29(3):172-83. PubMed ID: 11034115
[TBL] [Abstract][Full Text] [Related]
40. Melatonin Decreases Glucose Metabolism in Prostate Cancer Cells: A
Hevia D; Gonzalez-Menendez P; Fernandez-Fernandez M; Cueto S; Rodriguez-Gonzalez P; Garcia-Alonso JI; Mayo JC; Sainz RM
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
